Novavax NVAX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novavax's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novavax's accounts payable?
- Novavax (NVAX) reported accounts payable of $16.1M in Q1 2026.
- How has Novavax's accounts payable changed year-over-year?
- Novavax's accounts payable decreased by 52.9% year-over-year, from $34.16M to $16.1M.
- What is the long-term trend for Novavax's accounts payable?
- Over 5 years (2020 to 2025), Novavax's accounts payable has grown at a -14.7% compound annual growth rate (CAGR), from $54.33M to $24.58M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.